Jiangxi Sanxin Medtec Co Ltd operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangxi Sanxin Medtec Co Ltd with three other
companies in this sector in China:
Guangzhou Improve Medical Instruments Company Limited
sales of 549.96 million Chinese Renmimbi [US$78.47 million]
of which 94%
was Medical Industry),
Beijing Bohui Innovation Biotechnology Co Ltd
(622.09 million Chinese Renmimbi [US$88.77 million]
of which 53%
was Blood Product), and
Andon Health Company Limited
(563.88 million Chinese Renmimbi [US$80.46 million]
of which 98%
was medica instruments).
During the year ended December of 2018, sales at
Jiangxi Sanxin Medtec Co Ltd were 531.30 million Chinese Renmimbi (US$75.81 million).
increase of 31.6%
versus 2017, when the company's sales were 403.87 million Chinese Renmimbi.
This was the third consecutive year of growth at Jiangxi Sanxin Medtec Co Ltd.
Sales of Colocation saw an increase
that was more than double the company's growth rate: sales were up
442.1% in 2018, from
108,188.61 Chinese Renmimbi to 586,522.78 Chinese Renmimbi.